Related Experiment Video

Updated: May 21, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells

Roberto Bellucci1, Hong-Nam Nguyen, Allison Martin

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA, USA. Roberto_Bellucci@dfci.harvard.edu

The Journal of Clinical Investigation
|June 12, 2012
PubMed

Insights

Scientists identified genes helping tumors evade natural killer (NK) cells. Silencing JAK1 and JAK2 genes made tumor cells more vulnerable to NK cell attacks, suggesting new therapeutic strategies for cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • Natural killer (NK) cells are crucial for innate immunity against cancer.
  • Tumor cells develop resistance to NK cell lysis via poorly understood mechanisms.
  • Identifying genes involved in immune evasion is key for cancer therapy.

Purpose of the Study:

  • To identify genes that confer resistance to NK cell-mediated killing in human tumor cells.
  • To explore the role of identified genes in modulating tumor cell susceptibility to immune attack.

Main Methods:

  • Utilized a lentiviral shRNA library targeting over 1,000 human genes for a genetic screen.
  • Performed gene silencing experiments to assess effects on NK cell cytotoxicity.
  • Analyzed the impact of gene silencing on Interferon-gamma (IFN-γ) secretion.

Main Results:

  • Identified 83 genes promoting tumor cell resistance to NK cell-mediated killing.
  • Gene silencing of JAK1 and JAK2 significantly increased tumor cell susceptibility to NK cell lysis.
  • Silencing JAK1/JAK2 also enhanced IFN-γ secretion by NK cells.
  • JAK inhibitors demonstrated similar effects, increasing tumor cell vulnerability.

Conclusions:

  • JAK1 and JAK2 play a significant role in mediating tumor cell resistance to NK cell immunity.
  • Targeting JAK signaling pathways could enhance the efficacy of cancer immunotherapy.
  • Small molecule JAK inhibitors may possess dual therapeutic and immunologic benefits in cancer treatment.

More Related Videos

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro10:36

A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro

Published on: January 9, 2018

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...